Osteopontin: Correlation with phagocytosis by brain macrophages in a rat model of stroke

GLIA

Volumn 59, Issue 3, 2011, Pages 413-423

  Shin, Yoo Jin ^a   Lim Kim, Hong ^a   Choi, Jeong Sun ^a   Choi, Jae Youn ^a   Cha, Jung Ho ^a   Lee, Mun Yong ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Brain macrophages; Focal ischemia; Ischemic brain core; Osteopontin; Phagocytosis; White matter tract damage

Indexed keywords

MESSENGER RNA; OPSONIN; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; BRAIN ISCHEMIA; BRAIN PERFUSION; ELECTRON MICROSCOPY; EXTRACELLULAR SPACE; MACROPHAGE; MICROGLIA; NERVE CELL; NERVE FIBER; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; WHITE MATTER;

ANIMALS; AXONS; BRAIN; DISEASE MODELS, ANIMAL; MACROPHAGES; MALE; MYELIN SHEATH; OSTEOPONTIN; PHAGOCYTOSIS; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 78751690182     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21110     Document Type: Article

References (35)

1. Borges K, Gearing M, Rittling S, Sorensen ES, Kotloski R, Denhardt DT, Dingledine R. 2008. Characterization of osteopontin expression and function after status epilepticus. Epilepsia 49: 1675-1685.
2. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L. 2001. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294: 1731-1735.
3. Choi JS, Kim HY, Cha JH, Choi JY, Lee MY. 2007. Transient microglial and prolonged astroglial upregulation of osteopontin following transient forebrain ischemia in rats. Brain Res 1151: 195-202.
4. Csordás A, Mázló M, Gallyas F. 2003. Recovery versus death of "dark" (compacted) neurons in non-impaired parenchymal environment: Light and electron microscopic observations. Acta Neuropathol 106: 37-49.
5. Denhardt DT, Noda M, O'Regan AW, Pavlin D, Berman JS. 2001. Osteopontin as a means to cope with environmental insults: Regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107: 1055-1061.
6. Diaz-Sanchez M, Williams K, DeLuca GC, Esiri MM. 2006. Protein co-expression with axonal injury in multiple sclerosis plaques. Acta Neuropathol 111: 289-299.
7. Ellison JA, Barone FC, Feuerstein GZ. 1999. Matrix remodeling after stroke. De novo expression of matrix proteins and integrin receptors. Ann N Y Acad Sci 890: 204-222.
8. Ellison JA, Velier JJ, Spera P, Jonak ZL, Wang X, Barone FC, Feuerstein GZ. 1998. Osteopontin and its integrin receptor alphaνbeta3 are upregulated during formation of the glial scar after focal stroke. Stroke 29: 1698-1707.
9. Gallyas F, Csordás A, Schwarcz A, Mázló M. 2004 "Dark" (compacted) neurons may not die through the necrotic pathway. Exp Brain Res 160: 473-486.
10. Gallyas F, Kiglics V, Baracskay P, Juhász G, Czurkó A. 2008. The mode of death of epilepsy-induced "dark" neurons is neither necrosis nor apoptosis: An electron-microscopic study. Brain Res 1239: 207-215.
11. Gentleman SM, Nash MJ, Sweeting CJ, Graham DI, Roberts GW. 1993. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci Lett 160: 139-144.
12. Irving EA, Bentley DL, Parsons AA. 2001. Assessment of white matter injury following prolonged focal cerebral ischaemia in the rat. Acta Neuropathol 102: 627-635.
13. Kang WS, Choi JS, Shin YJ, Kim HY, Cha JH, Lee JY, Chun MH, Lee MY. 2008. Differential regulation of osteopontin receptors, CD44 and the alpha(v) and beta(3) integrin subunits, in the rat hippocampus following transient forebrain ischemia Brain Res 1228: 208-216.
14. Kim MD, Cho HJ, Shin T. 2004. Expression of osteopontin and its ligand, CD44, in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis J Neuroimmunol 151: 78-84.
15. Kövesdi E, Pál J, Gallyas F. 2007. The fate of "dark" neurons produced by transient focal cerebral ischemia in a non-necrotic and non-excitotoxic environment: neurobiological aspects. Brain Res 1147: 272-283.
16. Lee MY, Shin SL, Choi YS, Kim EJ, Cha JH, Chun MH, Lee SB, Kim SY. 1999. Transient upregulation of osteopontin mRNA in hippocampus and striatum following global forebrain ischemia in rats. Neurosci Lett 271: 81-84.
17. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. 1998. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 101: 1468-1478.
18. Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
19. Matsuo A, Lee GC, Terai K, Takami K, Hickey WF, McGeer EG, McGeer PL. 1997. Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: A potential mechanism for the generation of autoantigens. Am J Pathol 150: 1253-1266.
20. McKee MD, Nanci A. 1996. Secretion of Osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis. Anat Rec 245: 394-409.
21. Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, Doyle K, Lessov NS, Simon RP, Stenzel-Poore MP. 2005. Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab 25: 217-225.
22. Moxon-Emre I, Schlichter LC. 2010. Evolution of inflammation and white matter injury in a model of transient focal ischemia. J Neuropathol Exp Neurol 69: 1-15.
23. O'Regan A, Berman JS. 2000. Osteopontin: A key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81: 373-390.
24. Pedraza CE, Nikolcheva LG, Kaartinen MT, Barralet JE, McKee MD. 2008. Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: Implications for bone wound healing. Bone 43: 708-716.
25. Schack L, Stapulionis R, Christensen B, Kofod-Olsen E, Skov Sørensen UB, Vorup-Jensen T, Sørensen ES, Höllsberg P. 2009. Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J Immunol 182: 6943-6950.
26. Schroeter M, Zickler P, Denhardt DT, Hartung HP, Jander S. 2006. Increased thalamic neurodegeneration following ischaemic cortical stroke in osteopontin-deficient mice. Brain 129: 1426-1437.
27. Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Van Evercooren AB, Cirillo R, Kosco-Vilbois M, Feger G, Papoian R, Boschert U. 2004. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci 25: 707-721.
28. Shin YJ, Choi JS, Choi JY, Cha JH, Chun MH, Lee MY. 2010. Enhanced expression of vascular endothelial growth factor receptor-3 in the subventricular zone of stroke-lesioned rats. Neurosci Lett 469: 194-198.
29. Souza-Rodrigues RD, Costa AM, Lima RR, Dos Santos CD, Picanço-Diniz CW, Gomes-Leal W. 2008. Inflammatory response and white matter damage after microinjections of endothelin-1 into the rat striatum. Brain Res 1200: 78-88.
30. Tanaka T, Ueno M, Yamashita T. 2009. Engulfment of axon debris by microglia requires p38 MAPK activity. J Biol Chem 284: 21626-2136.
31. Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin JX, Ihara M, McGeer PL. 2002. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 924: 63-70.
32. Wang X, Louden C, Yue TL, Ellison JA, Barone FC, Solleveld HA, Feuerstein GZ. 1998. Delayed expression of osteopontin after focal stroke in the rat. J Neurosci 18: 2075-2083.
33. Yam PS, Dewar D, McCulloch J. 1998. Axonal injury caused by focal cerebral ischemia in the rat. J Neurotrauma 15: 441-450.
34. Yan YP, Lang BT, Vemuganti R, Dempsey RJ. 2009. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochem Int 55: 826-832.
35. Zhao C, Fancy SP, ffrench-Constant C, Franklin RJ. 2008. Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiol Dis 31: 209-217.